Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin

Name: Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin
License: Public Domain

AstraZeneca

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diabetes mellitus, type 2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 387132
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.